Ex Vivo Organ Cultures As Models to Study Bone Biology
Overview
Authors
Affiliations
The integrity of the skeleton is maintained by the coordinated and balanced activities of the bone cells. Osteoclasts resorb bone, osteoblasts form bone, and osteocytes orchestrate the activities of osteoclasts and osteoblasts. A variety of in vitro approaches has been used in an attempt to reproduce the complex in vivo interactions among bone cells under physiological as well as pathological conditions and to test new therapies. Most cell culture systems lack the proper extracellular matrix, cellular diversity, and native spatial distribution of the components of the bone microenvironment. In contrast, ex vivo cultures of fragments of intact bone preserve key cell-cell and cell-matrix interactions and allow the study of bone cells in their natural 3D environment. Further, bone organ cultures predict the in vivo responses to genetic and pharmacologic interventions saving precious time and resources. Moreover, organ cultures using human bone reproduce human conditions and are a useful tool to test patient responses to therapeutic agents. Thus, these ex vivo approaches provide a platform to perform research in bone physiology and pathophysiology. In this review, we describe protocols optimized in our laboratories to establish ex vivo bone organ cultures and provide technical hints and suggestions. In addition, we present examples on how this technical approach can be employed to study osteocyte biology, drug responses in bone, cancer-induced bone disease, and cross-talk between bone and other organs © 2020 The Authors. published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
Angiotensin II Promotes Osteocyte RANKL Expression via AT1R Activation.
Ren J, Marahleh A, Ma J, Ohori F, Noguchi T, Fan Z Biomedicines. 2025; 13(2).
PMID: 40002839 PMC: 11853621. DOI: 10.3390/biomedicines13020426.
Gonzalez-Gonzalez A, Alvarez-Iglesias I, Garcia-Sanchez D, Dotta M, Reyes R, Alfonso-Fernandez A Stem Cell Res Ther. 2025; 16(1):50.
PMID: 39920824 PMC: 11806587. DOI: 10.1186/s13287-025-04165-0.
Kaur J, Adhikari M, Sabol H, Anloague A, Khan S, Kurihara N Cancer Res. 2024; 84(23):3936-3952.
PMID: 39312185 PMC: 11611663. DOI: 10.1158/0008-5472.CAN-24-0857.
Finlay M, Hill L, Neag G, Patel B, Chipara M, Lamont H F1000Res. 2024; 12:357.
PMID: 38778815 PMC: 11109547. DOI: 10.12688/f1000research.130779.2.
Adhikari M, Kaur J, Sabol H, Anloague A, Khan S, Kurihara N Res Sq. 2024; .
PMID: 38558984 PMC: 10980159. DOI: 10.21203/rs.3.rs-4047486/v1.